Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00001 |
| Species: | Homo sapiens |
| Position : | chr3:148898000-148901500 |
| Year: | 2019 |
| Title: | PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Clear cell renal cell carcinoma |
| PMID: | 31431624 |
| MONDO: | MONDO:0005368 |
| Tissue: | Kidney |
| Tissue Ontology ID: | UBERON:0002113 |
| Cell Source: | 769p |
| CVCL ID: | CVCL_1050 |
| Cell Type: | Renal clear cell carcinoma cell |
| Cell Ontology ID: | CL:0002677 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq, ATAC-seq, 3C-seq |
| Low Throughput Method: | ChIP-qPCR, CRISPR Knockout, CRISPRi, Luciferase Reporter Assay, qRT-PCR, Western blot |
| Target gene : | CP |
| TF name : | PAX8 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| PAX8 | ID | netpath | 38 |
| PAX8 | Pathways in cancer | kegg | 321 |
| PAX8 | Thyroid cancer | kegg | 25 |
| PAX8 | Hs_Thyroid_Stimulating_Hormone_(TSH)_signaling_pathway_WP2032_89823 | wikipathways | 28 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00002 | chr3:148898000-148901500 | Kidney | Renal clear cell carcinoma cell | Clear cell renal cell carcinoma |
| E_00003 | chr3:148898000-148901500 | Kidney | Renal clear cell carcinoma cell | Clear cell renal cell carcinoma |
| E_00004 | chr3:148898000-148901500 | Kidney | Renal clear cell carcinoma cell | Clear cell renal cell carcinoma |